Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Julphar
Harvard Business School
Cipla
McKinsey
Covington

Generated: May 20, 2019

DrugPatentWatch Database Preview

Drug Price Trends for SM PAIN RELIEVER PM GELTAB

« Back to Dashboard

Drug Price Trends for SM PAIN RELIEVER PM GELTAB

Average Pharmacy Cost for SM PAIN RELIEVER PM GELTAB

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SM PAIN RELIEVER PM GELTAB 49348-0151-09 0.04274 EACH 2019-02-20
SM PAIN RELIEVER PM GELTAB 49348-0151-09 0.04273 EACH 2019-01-23
SM PAIN RELIEVER PM GELTAB 49348-0151-09 0.04392 EACH 2018-12-19
Drug Name NDC Price/Unit ($) Unit Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
Baxter
Teva
QuintilesIMS
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.